UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea‐predominant irritable bowel syndrome measured using serial MRI

Neurogastroenterology and motility, 2014-01, Vol.26 (1), p.124-130

2014

Link zum Volltext

Verfügbarkeit prüfen

Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief

Clinical gastroenterology and hepatology, 2021-01, Vol.19 (1), p.80-86

2021

Link zum Volltext

Verfügbarkeit prüfen

LncRNA H19 as a Competing Endogenous RNA to Regulate AQP Expression in the Intestinal Barrier of IBS-D Patients

Frontiers in physiology, 2021-01, Vol.11, p.602076-602076

2021

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Health and quality of life outcomes, 2017-02, Vol.15 (1), p.35-35, Article 35

2017

Link zum Volltext

Verfügbarkeit prüfen

Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats

Frontiers in microbiology, 2022-11, Vol.13, p.1024822-1024822

2022

Link zum Volltext

Verfügbarkeit prüfen

Diet and Management of Diarrhea

Indian journal of pediatrics, 2023-07

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome

Frontiers in physiology, 2022-11, Vol.13, p.1039804-1039804

2022

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron

Alimentary pharmacology & therapeutics, 2019-09, Vol.50 (5), p.538-546

2019

Link zum Volltext

Verfügbarkeit prüfen

Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D

Frontiers in pharmacology, 2023-03, Vol.14, p.1062630-1062630

2023

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

Frontiers in pharmacology, 2022-11, Vol.13, p.1075874-1075874

2022

Link zum Volltext

Verfügbarkeit prüfen

TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: Implications for multiple nutrient ingestion abnormality

Journal of proteomics, 2021-01, Vol.231, p.103995, Article 103995

2021

Link zum Volltext

Verfügbarkeit prüfen

Single‐dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment

Clinical pharmacology in drug development, 2023-02, Vol.12 (2), p.132-140

2023

Link zum Volltext

Verfügbarkeit prüfen

Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial

Journal of ethnopharmacology, 2022-05, Vol.289, p.115064-115064, Article 115064

2022

Link zum Volltext

Verfügbarkeit prüfen

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Nutrients, 2021-04, Vol.13 (5), p.1506

2021

Link zum Volltext

Verfügbarkeit prüfen

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier

Gut, 2013-08, Vol.62 (8), p.1160-1168

2013

Link zum Volltext

Verfügbarkeit prüfen

Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

Frontiers in pharmacology, 2022-09, Vol.13, p.955421-955421

2022

Link zum Volltext

Verfügbarkeit prüfen

Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways

Journal of ethnopharmacology, 2021-05, Vol.272, p.113925-113925, Article 113925

2021

Link zum Volltext

Verfügbarkeit prüfen

Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome

Clinical and translational gastroenterology, 2024-02, Vol.15 (2), p.e00658-e00658

2024

Link zum Volltext

Verfügbarkeit prüfen

Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice

Biomedicine & pharmacotherapy, 2019-10, Vol.118, p.109206-109206, Article 109206

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and potential functions of tRNA-derived small RNAs (tsRNAs) in irritable bowel syndrome with diarrhea

Pharmacological research, 2021-11, Vol.173, p.105881-105881, Article 105881

2021

Link zum Volltext

Verfügbarkeit prüfen

MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1

Cellular physiology and biochemistry, 2018-01, Vol.44 (6), p.2256-2268

2018

Link zum Volltext

Verfügbarkeit prüfen

Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism

Frontiers in endocrinology (Lausanne), 2022-11, Vol.13, p.1053103-1053103

2022

Link zum Volltext

Verfügbarkeit prüfen

The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

Journal of ethnopharmacology, 2021-07, Vol.275, p.114119, Article 114119

2021

Link zum Volltext

Verfügbarkeit prüfen

Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome

Life sciences (1973), 2018-11, Vol.212, p.176-181

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Ibs-D
(47)
Irritable Bowel Syndrome
(37)
Humans
(32)
Diarrhea
(25)
Female
(20)
Male
(19)
Pharmacology & Pharmacy
(17)
Adult
(16)
Gastroenterology & Hepatology
(16)
Middle Aged
(16)
Ibs
(15)
Irritable Bowel Syndrome - Complications
(12)
Irritable Bowel Syndrome - Physiopathology
(12)
Intestine
(11)
Pain
(11)
Gastroenterology
(10)
Ibs-C
(10)
Irritable Bowel Syndrome - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea‐predominant irritable bowel syndrome measured using serial MRI

Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief

LncRNA H19 as a Competing Endogenous RNA to Regulate AQP Expression in the Intestinal Barrier of IBS-D Patients

Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats

Diet and Management of Diarrhea

Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome

Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron

Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D

Corrigendum: Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: Implications for multiple nutrient ingestion abnormality

Single‐dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment

Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier

Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways

Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome

Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice

Identification and potential functions of tRNA-derived small RNAs (tsRNAs) in irritable bowel syndrome with diarrhea

MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1

Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism

The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies

Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome

Suchergebnisse filtern